Page last updated: 2024-12-08

daunosamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

daunosamine: amino sugar moiety common to adriamycin & daunomycin; RN given refers to (L-lyxo)-isomer; see also ristosamine, (L-ribo)-isomer: 51869-30-8 & acosamine, (L-arabino)-isomer: 41094-24-0; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID419075
CHEMBL ID2009445
SCHEMBL ID7089370
MeSH IDM0050267

Synonyms (12)

Synonym
NSC110344 ,
daunosamine
19196-51-1
3-amino-4,5-dihydroxy-hexanal
NCI60_000244
3-amino-4,5-dihydroxyhexanal
nsc 110344
CHEMBL2009445
SCHEMBL7089370
3-amino-2,3,6-trideoxyhexose
FT-0699974
l-daunosaminehcl
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (25.00)18.7374
1990's9 (28.13)18.2507
2000's7 (21.88)29.6817
2010's7 (21.88)24.3611
2020's1 (3.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]